This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs covered by Medicare or Medicaid to include the list price of the medicine.

To be sure, a free market is dependent on consumers making informed decisions. But this move would provide patients with incomplete, misleading numbers that would muddle their healthcare decisions.

Recommended Stories

Insurers’ exclusion of disease treatments increases costs

Pharmacy benefit manager reform must remain a priority for Congress

Pharmacy benefit managers are working hard for patients